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Abstract
Background
Clinical trials are most informative for evidence-based decision-making when they consis-
tently measure and report outcomes of relevance to stakeholders, especially patients, clini-
cians, and policy makers. However, sometimes terminology used is interpreted differently
by different stakeholders, which might lead to confusion during shared decision making. The
construct dialysis adequacy is frequently used, suggesting it is an important outcome both
for health care professionals as for patients.
Objective
To assess the scope and consistency of the construct dialysis adequacy as reported in ran-
domised controlled trials in hemodialysis, and evaluate whether these align to the insights
and understanding of this construct by patients.
Methods
To assess scope and consistency of dialysis adequacy by professionals, we performed a
systematic review searching the Cochrane Central Register of Controlled Trials (CENTRAL)
up to July 2017. We identified all randomised controlled trails (RCT) including patients on
hemodialysis and reporting dialysis adequacy, adequacy or adequacy of dialysis and
extracted and classified all reported outcomes. To explore interpretation and meaning of the
construct of adequacy by patients, we conducted 11 semi-structured interviews with HD
patients using thematic analysis. Belgian registration number B670201731001.
Findings
From the 31 included trials, we extracted and classified 98 outcome measures defined by
the authors as adequacy of dialysis, of which 94 (95%) were biochemical, 3 (3%) non-bio-
chemical surrogate and 2 (2%) patient-relevant. The three most commonly reported mea-
sures were all biochemical. None of the studies defined adequacy of dialysis as a patient
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relevant outcome such as survival or quality of life. Patients had a substantially different
understanding of the construct dialysis adequacy than the biochemical interpretation
reported in the literature. Being alive, time spent while being on dialysis, fatigue and friendli-
ness of staff were the most prominent themes that patients linked to the construct of dialysis
adequacy.
Conclusion
Adequacy of dialysis as reported in the literature refers to biochemical outcome measures,
most of which are not related with patient relevant outcomes. For patients, adequate dialysis
is a dialysis that enables them to spend as much quality time in their life as possible.
Introduction
Over 2 million people worldwide receive dialysis, and this number is only a fraction of the peo-
ple that theoretically would need it [1]. Although considered a life prolonging technique, the
5-year survival rate of people on dialysis is only 63.3%, and even lower when adjusted for attri-
tion by kidney transplantation [2]. Although a small positive evolution in survival can be seen
over the years, big improvements are lacking despite numerous studies. Next to the unsatisfac-
tory survival rates, overall quality of life is also poor and the burden of disease high, with lower
health related quality of life (HRQOL) [3] indices in hemodialysis patients as compared to the
general population [4]. The amount of high quality evidence in nephrology is rather low, and
harmonization of outcome measures to allow meta-analysis of data across studies to enhance
evidence generation, is lacking[5, 6]. If we intend to improve the overall care of dialysis
patients, it is essential to identify outcomes relevant to all stakeholders so these can be focused
on in future research, and to ensure that these outcomes are measured and reported uniformly
to allow data aggregation and meta-analysis. The Standardised Outcomes in Nephrology
Hemodialysis (SONG-HD) initiative was the first international collaboration that tried to gen-
erate this set of ‘core outcomes’ for hemodialysis patients[7, 8]. Core outcomes are based on
the shared priorities of patients, caregivers and health professionals and are important for deci-
sion making. To reduce research waste and increase available evidence, it is essential that all
trials include core outcomes as primary or secondary outcome. To generate such a list, the
SONG initiative used a validated 5-phase protocol, using several methods and combining qual-
itative and quantitative data[5]. The construct adequacy of dialysis was mentioned as an impor-
tant outcome by patients and health care providers at this stage of the process. However, the
meaning of the construct of adequacy of dialysis might not be straightforward. The term was
coined in the 70s of last century, and gained momentum with the advent of the US National
Cooperative Dialysis Study demonstrating greater patient withdrawal from the study and
more hospitalizations in the group with the highest blood urea concentrations[9]. In this
study, treatment failures were associated with fractional small solute clearance, expressed as
urea Kt/V[9]. Since then, different methods to calculate Kt/V have been introduced[10]. More
essential, there was increasing acknowledgment that urea per se is not very toxic, and that its
behavior during dialysis might not reflect that of potentially more toxic solutes, such as middle
molecules or protein bound solutes[11–13]. In addition, different authors argued that dialysis
adequacy should also cover control of uremic symptoms, extracellular volume and blood pres-
sure, and improve survival and quality of life[14]. It can thus be expected that the construct
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adequacy of dialysis as reported in randomized controlled trials or used in the literature, covers
a broad scope of substantially different items.
Over the last decade, increasing emphasis has been placed on patient involvement and
patient centredness of care. Shared decision making can be an helpful tool to enhance patient
centredness, as the technique maximizes the probability that interventions will result in out-
comes meaningful to patients[15]. To achieve this, it is essential that sufficient quality data on
the link between an intervention and the relevant outcomes are available, and that both profes-
sionals and patients use a uniform, unambiguous and unequivocal language.
Therefore, the aim of this review is to evaluate the scope and consistency of the term dialysis
adequacy used in randomised clinical trials and explore in how far this construct as reported
in the literature corresponds to what patients envision from it. Therefore, we performed a sys-
tematic review of the definitions of the term adequacy of dialysis and dialysis adequacy used in
randomised controlled trials. We also performed semi-structured interviews to explore
patient’s views and understanding on this construct.
Materials and methods
Systematic review
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) and Pubmed to
identify all randomised controlled trails (RCT) up to July 2017 including adult (>18 years)
patients on hemodialysis (P) and reporting dialysis adequacy, adequacy or adequacy of dialysis
either as outcome or as covariate in the analysis (O). We restricted papers to those in English,
Dutch, French or Spanish (Fig 1).
In a first round, we excluded papers not fitting the in- and exclusion criteria based on title
and abstract. From the remaining studies, we retrieved full texts. We excluded trials that did
not include adult patients (18 years of age), studied acute hemodialysis or did not mention ade-
quacy, dialysis adequacy or adequacy of dialysis in the paper.
For each trial, we extracted the following trial characteristics: first author, year of publica-
tion, participating countries, sample size, mean age of participants, average study duration,
and intervention type. Further, all constructs designated as dialysis adequacy, adequacy of dial-
ysis or adequacy where extracted and counted. As we intended to understand the meaning
attributed to dialysis adequacy, adequacy or adequacy of dialysis, we counted all constructs
depicted as such in the papers reporting the study, even if this was not the primary or second-
ary outcome of the study. For example, when a study reported on the association between ade-
quacy of dialysis as defined by Kt/Vurea and quality of life, we counted Kt/Vurea and not
quality of life as representing adequacy. For each construct, we extracted domain (e.g. clear-
ance or reduction rate), specific measurement (e.g. urea or creatinine), and timing in relation
to the commencement of the trial if applicable. We used studies as measure of unity, so that
outcomes of one single study that are reported in different papers on that study are only
counted once.
Paper selection and data extraction was done in duplicate (SS and EH). In case of doubt,
the item was discussed in the group, and WVB and EN made a final decision.
Per individual item, the total number of times it was used was tabulated and graphically
depicted using an Excel work sheet. Items were divided in three major categories: Biochemical
(validated or non-validated), non-biochemical surrogate (validated or non-validated) and
patient relevant outcomes (relating to clinical items, patient reported outcomes and quality of
life). Within each category, when applicable, further distinction was made for different
domains (eg clearance, reduction ration, or concentration) and different metrics (eg urea or
creatinine) within this domain.
Dialysis adequacy standardised outcomes
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Semi structured interviews of hemodialysis patients
To check the match of definitions of the construct dialysis adequacy in trials with the under-
standing of patients, the latter was explored using qualitative methods. Semi-structured inter-
views were conducted with patients on hemodialysis to ascertain the range of their
understanding of the construct dialysis adequacy, adequacy and adequacy of dialysis. The Con-
solidated Criteria for Reporting Qualitative Health Research (COREQ) were used as reference
[16]. The study was approved by the Ethical Committee of the Ghent University Hospital (2/
2017) and registered with the Belgian registration number B670201731001.
Fig 1. PRISM flow chart of systematic review.
https://doi.org/10.1371/journal.pone.0207045.g001
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Patients with in center hemodialysis were recruited to participate in an interview. The
semi-structured interviews were performed in a non-university, non-for profit dialysis unit
with 18 dialysis posts next to a 300 bed regional hospital in Flanders, Belgium, serving an area
of approximately 60.000 people. From this unit, participants were recruited of different age,
gender, social background and education using purposive sampling. Written informed con-
sent was obtained from all participants. Inclusion criteria were in center hemodialysis patients
age>18years with enough knowledge of French, Dutch or English to create a good contact
between interviewer and patient. Patients were excluded when they had important cognitive
dysfunction, or were acutely ill.
An interview guide was devised with the following question to prompt the patients to dis-
cuss the relevant themes (S1 Table):
1/ Do you know the term “adequacy of dialysis” and what is your understanding of this con-
struct; 2/ what does this construct of “adequacy of dialysis” mean to you personally as a patient;
3/ In literature, “adequacy of diaysis” mainly represents a mathematical (calculated) value
based on the amount of urea or one of the other toxins that poison your body if you have
severe kidney disease; how do you think about this approach?; 4/ How well do you think that
“adequacy of dialysis” as represented in literature reflects “good dialysis”? What would “good
dialysis mean to you?
Interviews were conducted face-to-face, at the location preferred by the patient. The inter-
view took between 10 minutes and 30 minutes, was audio-taped and transcribed verbatim.
Thematic analysis was used to identify the themes reflecting perspectives, beliefs, priorities,
and values of patients on hemodialysis regarding dialysis adequacy using Nvivo12. Two inves-
tigators (SS, MVDV) coded and analyzed the data to develop a first descriptive and analytical
identification of themes, which were discussed with WVB and SM (investigator triangulation).
Draft results were presented to and discussed with interviewed patients (member checking).
Results
Systematic research
We identified 35 articles from 31 trials (Table 1, Fig 1). With publication dates varying between
1996 and 2016, trials were primarily performed in Europe (13) and North-America (12). Apart
from the HEMO-study (5 included trials), there were only two trials in which the number of
study participants exceeded 100, and the median number of participants was 39.5 with an
interquartile range of 64 (first quartile 15, third quartile 79). Studies were reported as single
center trials in 54.8%, and as multicenter investigations in 38.7%, whereas in 3 trials, this was
not specified. Only 22% of the studies had a duration of six months or more. All studies com-
bined, the mean age of participants ranged between 55.9 and 74 year.
The total number of unique markers reported as adequacy of dialysis was 98, of which 49
were already provided in one single study. The median number of parameters reported as ade-
quacy of dialysis per study was only two. Out of the total of 98 markers, only 5 were not bio-
chemical: mean blood flow, dialyzer surface, recirculation, dialysis time, reliability of access.
Except for the blood flow, which was used in three different trials, each of the other patient-rel-
evant and surrogate non-biochemical parameters were only used once.
Every trial used at least one biochemical parameter to represent adequacy of dialysis. The
most commonly used parameter was Kt/V (87% of the studies). There were several formulas to
calculate this however, spKt/V being the most popular method. The second most commonly
used parameters was the urea reduction ratio (URR), used by 58% of the trials.
As visible from Fig 2, the percentage of the number of trials that reported one of the other
specific outcomes declined quickly after these two major indicators. Only clearance of some
Dialysis adequacy standardised outcomes
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Table 1. Trial characteristics.
Author Title Country Participants
(N)
Outcomes for adequacy
of dialysis (N)
Atherikul, 1998 [44] Adequacy of haemodialysis with cuffed central-vein catheters. USA 64 6
Basile, 2011[45] Removal of uraemic retention solutes in standard bicarbonate haemodialysis and
long-hour slow-flow bicarbonate haemodialysis.
Italy 11 49
Chang, 2001[46] Creatine monohydrate treatment alleviates muscle cramps associated with
haemodialysis.
Taiwan 10 1
Chow, 2011[47] Randomized controlled trial protocol on buttonhole cannulation: A technique to
reduce arteriovenous fistula access complications.
Australia 70 1
The HEMO study
[32, 48–50]
The HEMO study USA 1846 3
Dhondt, 2015[51] Where and when to inject low molecular weight heparin in hemodiafiltration? A cross
over randomised trial.
Belgium 13 2
Fritz, 2003[52] A comparison of dual dialyzers in parallel and series to improve urea clearance in
large hemodialysis patients.
USA 18 14
Furuland, 2005[53] Reduced hemodialysis adequacy after hemoglobin normalization with epoetin. Sweden 33 3
Gutzwiller, 2002[54] Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis
dose.
Switzerland 18 4
Hwang, 2012[55] Comparison of the palindrome vs. step-tip tunneled hemodialysis catheter: a
prospective randomized trial.
South
Korea
97 2
Kirkman, 2013[56] Interaction between intradialytic exercise and hemodialysis adequacy. UK 11 14
Krieter, 2005[57] Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel
dialyzer concept and post-dilution hemodiafiltration.
France 10 15
Kloppenburg, 2004
[58]
Effect of prescribing a high protein diet and increasing the dose of dialysis on
nutrition in stable chronic haemodialysis patients
Netherlands 34 6
Li, 2011[59] Effect of short-term low-protein diet supplemented with keto acids on
hyperphosphatemia in maintenance hemodialysis patients.
China 40 1
Locatelli, 2000[60] Effect of high-flux dialysis on the anaemia of haemodialysis patients. Italy 84 1
Mactier, 1997[61] Comparison of high-efficiency and standard haemodialysis providing equal urea
clearances by partial and total dialysate quantification.
UK 6 15
McClellan, 2004[62] A randomized evaluation of two health care quality improvement program (HCQIP)
interventions to improve the adequacy of hemodialysis care of ESRD patients:
feedback alone versus intensive intervention.
USA ns 1
Meert, 2011[63] Comparison of removal capacity of two consecutive generations of high-flux dialysers
during different treatment modalities.
Belgium 14 11
Nassar, 2014[64] A comparison between the HeRO graft and conventional arteriovenous grafts in
hemodialysis patients.
USA 72 3
Parker, 1997[65] Safety and efficacy of low-dose subcutaneous erythropoietin in hemodialysis patients. USA 27 8
Pereira, 1996[66] Impact of single use versus reuse of cellulose dialyzers on clinical parameters and
indices of biocompatibility.
USA 37 1
Power, 2014[67] Comparison of Tesio and LifeCath twin permanent hemodialysis catheters: the VyTes
randomized trial.
UK 80 1
Powers, 1999[68] Improved urea reduction ratio and Kt/V in large hemodialysis patients using two
dialyzers in parallel.
USA 14 6
Richardson, 2003
[69]
A randomized, controlled study of the consequences of hemodialysis membrane
composition on erythropoietic response
UK 176 2
Rocha, 2014[70] Effects of citrate-enriched bicarbonate based dialysate on anticoagulation and dialyzer
reuse in maintenance hemodialysis patients.
Brasil 28 1
Sangthawan, 2011
[71]
Comparison of dialysis adequacy at two dialysate potassium concentrations. Australia 10 2
Sehgal, 2002[72] Improving the quality of hemodialysis treatment: a community-based randomized
controlled trial to overcome patient-specific barriers.
USA 213 3
Tawney, 2000[73] The life readiness program: a physical rehabilitation program for patients on
hemodialysis.
USA 82 1
(Continued)
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small molecules (9.6%), the reduction rate of creatinine (9.6%) and beta-2 microglobulin
(16.1%) were used in at least three articles. The implementation of other markers was some-
times suggested in the article, but not specifically used within the trial.
Semi-structured interviews
Patient demographics are represented in Table 2.
Only 1 out of the 11 patients explained adequacy of dialysis as the degree of removal of
waste products. When we reframed the question as ‘good dialysis’, 5 out of 11 patients indi-
cated that dialysis was good simply because they were still alive, and they accepted this treat-
ment in order to live longer.
In almost every interview, patients indicated they did not have a choice but come to dialysis.
They could either conform to the suggested treatment, or they would die. Some clearly stated
they were happy dialysis existed because it allowed them to live longer. The time spent on dial-
ysis was the price they had to pay. Ways of dealing with the lost time were rationalization and
comparison. One patient mentioned that for her, adequacy was the usefulness of dialysis. It
allowed her to live a free and normal live in between sessions.
“When you poison your own body, I am content this exists so they can help me. I need to come
here three times a week but it is something you have to do. . .if you want to live that is” patient
2, male, 64y
“It has to happen, otherwise I die. You don’t have a choice”. Patient 11, male
“If there is no other option. You are happy to accept it then”. Patient 9, male, 69y
Other themes that emerged during the interviews were clustered around 1/organization of
their life and time in relation to dialysis; 2/ physical experience of dialysis; 3/ social and exter-
nal factors; 4/ coping; 5/ dialysis related themes (Table 3).
The time people spent for their dialysis frequently emerged as a theme. Patients considered
longer dialysis sessions as inversely correlated with good dialysis. Although the time spent
actually on dialysis was most frequently quoted, also time spent with transport or waiting to be
connected were often mentioned. Remarkably, all interviewed patients would accept longer or
more dialysis sessions if there was certain proof it would improve their survival or quality of
life.
Some patients mentioned flexibility in the timing of the dialysis session as a major aspect of
“adequate dialysis”.
“There are nurses that complain when I am five or ten minutes late. But don’t forget, I can’t
make it on time when there is work.” patient 5, male, 56y
Table 1. (Continued)
Author Title Country Participants
(N)
Outcomes for adequacy
of dialysis (N)
Wang, 2008[74] The effect of increasing dialysis dose in overweight hemodialysis patients on quality of
life: a 6-week randomized crossover trial.
Canada 18 1
Afaghi, 2015[75] The effect of BCAA and ISO-WHEY oral nutritional supplements on dialysis
adequacy
Iran 61 2
Islam, 2016[76] Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free
Hemodialysis: a Multicenter, Randomized, Crossover Trial
France 28 3
https://doi.org/10.1371/journal.pone.0207045.t001
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Importantly, most patients consider also the wash out period and the period with lack of
energy after a dialysis session as “wasted time”
“One time, I had to come three days in a row. I don’t know the reason anymore but it was too
much. I can’t handle it. I was so tired, no energy for anything.” Patient 4, female
Fig 2. Outcome domains and metrics used to represent adequacy of dialysis in randomized controlled trials.
https://doi.org/10.1371/journal.pone.0207045.g002
Dialysis adequacy standardised outcomes
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Some patients considered the time on dialysis as an opportunity to rest or sleep so they
have more energy in between dialysis sessions.
“I come here to rest for four hours. Here I can sleep if I want”, patient 9, male, 69y
Fatigue was an ambivalent theme in dialysis adequacy. While some people explained they
knew dialysis was adequate because they felt very tired before the start of dialysis and less so
after, more mentioned fatigue as an unwanted consequence of dialysis, impairing their social
life and activities of daily living. Longer dialysis times were often associated with more fatigue,
which made that this dialysis was perceived as less good.
“When I return from dialysis, I am always tired and have to rest.” Patient 3, female
Interaction with others during dialysis was seen as an important aspect of good dialysis.
Friendliness of staff, mainly nurses, was an often cited theme (5/11), followed by being able to
have a chat with fellow patients (4/11). This theme was related to spending time on dialysis, as
being able to interact with others made time go by quicker and more meaningful.
Table 2. Demographics of patients included in the semi-structured interviews.
Gender (M/F) 6/5
Age (years) 65±12
Time on dialysis (months) 36±33
Underlying kidney disease Diabetes (n = 4)
Cardiovascular (n = 4)
Genetic (n = 2)
Nephrectomy (n = 1)
Average ultrafiltration (ml/hour) 410±218
On transplant waiting list (Y/N) 3/8
Vascular access AV fistula (n = 6)
Tunneled catheter (n = 5)
https://doi.org/10.1371/journal.pone.0207045.t002
Table 3. Themes from the semi-structured interviews.
Being alive/ Coping - Acceptation as essential and life saving treatment
- Living a normal live in between sessions
- Rationalization
- Comparison to other disease conditions
Time spent on dialysis related issues. - Duration and frequency
- Flexibility of dialysis session
- Ways to spend time on dialysis
- Fatigue
Friendliness of staff and social factors - Rapport with other patients
- Rapport with staff (nurses and doctors)
- Friendliness of staff
- Feedback of doctors
- Comfort
- Immobilization
Dialysis related themes - Alarms of the dialysis machine
- Ultrafiltration setting
- Removal of waste products
- Muscle cramps
- Hypotension/hypertension
- Peripheral edema
- Vascular access
https://doi.org/10.1371/journal.pone.0207045.t003
Dialysis adequacy standardised outcomes
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“The atmosphere and the people. They are all nice people and nurses. For me, that is the
important thing. If you cannot chat with anyone or have a laugh. . . dialysis is not pleasant
because it takes so long. If nobody talks, it’s so long.” Patient 6, female, 68y
Discussions and conflicts with nurses on the other hand could diminish the perception of
good dialysis.
“Nurses should not be allowed to mess around with you”. Patient 5, male, 56y
The importance of communication with doctors specifically was not spontaneously men-
tioned when talking about good dialysis. A good dialysis implied doctors didn’t complain to
the patients about laboratory values. However, feedback was appreciated. Patients used it to
see if the current diet restrictions were sufficient. When levels of potassium and phosphorus
were abnormal, patients stated they had to adjust some eating habits but they did not link it
directly with the adequacy of dialysis. For example, although one person would wish for a bet-
ter cleansing of the blood so she could have more liberty when eating, when there was hyper-
phosphatemia or hyperkalemia, she would explain it by dietary factors.
“A good dialysis is when it everything goes well. When they (doctors) complain, I don’t like it.”
Patient 4, female
The physical changes associated with dialysis could be divided between positive and nega-
tive aspects. The development of peripheral edema before and the disappearance of it after
dialysis was a way to see that the dialysis works, as were the difference in weight and blood
pressure control.
“My legs are less swollen” (explaining why hemodialysis is better than peritoneal dialysis)
patient 1, female, 72y
The removal of toxins was only brought up by one person when discussing adequacy of
dialysis.
“I think a good dialysis mainly means that the clearance of the blood happens in the right way
and good way.” Patient 10, female, 38y
Four people mentioned aspects of the dialysis machine as related with adequacy of dialysis.
2 people followed the amount of ultrafiltration that was set to see if they were strict enough in
their fluid intake. A low ultrafiltration need was seen as a good dialysis. Muscle cramps and
hypotension were blamed on ultrafiltration, and a dialysis session was considered as good
when they could be avoided.
“Sometimes my blood pressure drops, then they stop taking fluids away”. Patient 6, female,
68y
Alarms were seen as a sign of a less good dialysis by 4/11 patients.
“A good dialysis is when there are not many alarms. That is a sign that everything goes
smoothly.” Patient 7, male, 69y
Dialysis adequacy standardised outcomes
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Vascular access related topics also emerged during most of the interviews. Although they
were never directly linked to adequacy of dialysis, it appeared vascular access has an impact on
quality of life of dialysis patients in different ways: fear for problems with access as a lifeline,
stress that problems would complicate sessions, capacity for bathing and showers, body disfig-
uration, prolonged bleeding post-dialysis
When you have a catheter, you cannot take a proper bath, or even shower yourself. Patient 6,
female, 68 years
The bleeding did not stop, and I had to return to the emergency department. Patient 4, female
Discussion
The results of the quantitative part of our study indicate that the construct adequacy of dialysis
is defined substantially differently in different studies. An overwhelming majority of the con-
structs are based on biochemical surrogate markers, most frequently Kt/Vurea, which in itself is
not uniformly defined however, and urea reduction rate. Patient relevant and surrogate non
biochemical parameters were infrequently reported as adequacy of dialysis. The qualitative
results of our research demonstrate that the definitions used in randomized controlled trials
do not reflect what patients value as adequate dialysis. The main themes patients brought for-
ward to represent adequacy of dialysis were being alive, time spent on dialysis, fatigue and
friendliness of staff and ability for socializing. These themes were in line with previous work
[17, 18]
In randomized controlled trials, the removal of small molecules, more specifically Kt/V and
the urea reduction rate (URR) are the most commonly used parameters to reflect dialysis ade-
quacy, with 100% of the studies using at least one of them. URR is probably one of the oldest
markers used to measure the dose of dialysis[19], but is considered as a rather rough marker of
solute removal, as it does not allow to take into account the impact of compartmental behavior
of solutes. In a mechanistic post hoc analysis of the randomized National Cooperative Dialysis
Study, Kt/V was developed as a measure of prescribed dialysis dose and as a marker to evaluate
if an adequate dialysis was delivered. This study coined the terms adequate dialysis and ade-
quacy of dialysis treatment, basing the validity of this on the observed association of Kt/V with
the morbidity of the patient[9].
Since the initial publication, several ways to calculate Kt/V have been developed[20–25]. In
some jurisdictions, Kt/V is being used as a quality indicator, often even in a summative way. It
can be postulated however that adapting the use of Kt/V as an indicator of adequacy of dialysis
has several limitations. First and foremost, all associations between Kt/Vurea and relevant out-
comes are observational, and a proven effect on mortality of changing Kt/V, in whichever
form this is calculated, has never been convincingly demonstrated in a randomized controlled
trial. Second, focusing on this parameter as the measure for dialysis adequacy ignores the fact
that other retention products in uremia are potentially more toxic than urea. In 2012, the
European Uremic Toxin Work Group described 88 uremic retention solutes [26, 27], many of
them with proven toxicity. Indoxyl sulfate for example is associated with vascular inflamma-
tion, endothelial dysfunction and vascular calcification and p-cresylsulphate is a predictor of
mortality in patients with varying degrees of kidney impairment [28, 29]. As the kinetic behav-
ior of urea and these toxins during dialysis is substantially different from that of urea, Kt/Vurea
poorly reflects the removal of these uremic toxins during dialysis [13, 30]. Reduction ratios of
other molecules than urea have also been used in RCTs, but for none of these solutes, indices
that take into account compartmental behavior or allow to quantify solute removal, have been
Dialysis adequacy standardised outcomes
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developed. Within scientific research, adequacy of dialysis indicate substantially different con-
cepts, and in fact poorly reflects removal of the truly toxic substances. The numerous ways of
calculating Kt/Vurea, all reported as adequacy of dialysis, make it hard or even impossible to
compare results or perform meta-analyses on the topic, further reducing their evidence gener-
ating capacity. None of these aforementioned biochemical markers did come up in the patient
interviews. Only one patient identified adequacy of dialysis as sufficient removal of waste
products. This patient was the youngest and had the highest education level.
For all these reasons, placing Kt/Vurea and adequacy of dialysis on the same line is cumber-
some as the evidence to underpin that better Kt/Vurea results in better patient relevant out-
comes is largely lacking.
For the graphical and hierarchical classification of the outcomes reported as adequacy of
dialysis, we used a framework adapted from that used in the SONG-HD initiative[18] and the
OMERACT initiative[31]. Within the framework, outcome domains are categorized as having
vital impact (death), having life impact, and pathophysiological manifestations (surrogate
markers). For outcomes labelled as adequacy of dialysis, the overwhelming majority of out-
comes can be considered as outer tier, as they are purely based on biochemical markers, and
have not been validated as being linked in a causal way to patient relevant outcomes. Only a
very limited amount of studies used patient relevant outcomes such as quality of life. Neither
Kt/Vurea nor URR have been validated in a RCT as surrogate markers for higher tier outcomes
such as survival or quality of life. In fact, the largest RCT in this regard, the HEMO trial, dem-
onstrates no difference in survival with increasing Kt/Vurea [32] Again, the evidence base com-
piled around the construct of adequacy of dialysis is thus very weak, and offers little guidance
in decision making because as it lacks studies using robust, meaningful and patient relevant
outcomes.
According to the requirements for a quality indicator to be valid for summative monitoring
[33], there should be no undesired side effects. This criterium is probably violated when Kt/
Vurea is used as adequacy parameter. As time and clearance are aspects of this formula, opti-
mizing Kt/Vurea values can mean either increasing duration of the dialysis session or increasing
the clearance. In the SONG-HD project, dialysis-free time was rated more important by the
different stakeholders than relieve of certain uremic symptoms [18, 34]. A higher clearance
can be achieved by applying higher blood flows or by extending the dialysis duration. The
request for higher blood flows can result in a higher number of interventions for vascular
access improvement and more hospitalizations. Both of these can have a strong negative
impact on quality of life of patients. This might explain why the degree of relation between
dose, timing and frequency of dialysis on one hand and quality of life on the other hand is
inconsistent in clinical trials [27]. Of note, in SONG concerns on vascular access ranked as
critically relevant amongst patients[35]. In our qualitative analysis, many patients mentioned
topics related to their vascular access which can be linked to quality time, such as prolonged
bleeding, missed punctures and pain for fistulas and disturbed body image for catheters.
Recently, much attention has been paid to the need to improve removal of middle molecules,
such as beta 2 microglobulin and pro-inflammatory peptides by using high volume hemodia-
filtration. These technically more complex treatments might also have downsides in the form
of more frequent need for vascular access revision, more alarms and longer duration of dialysis
because of technical problems. It is important that both potential positive effects (longer sur-
vival, less comorbidity) and negative effects (time actually spend on dialysis, need for vascular
access interventions, alarms. . .) are quantified in a way patients can understand and interpret,
so they can balance their priorities. Simply demonstrating that such approaches reduce surro-
gate markers as beta 2 microglobulin will not be sufficient.
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In contrast however to the biochemical definitions of adequacy of dialysis, longer duration
of the dialysis session has been associated to improved survival [36, 37]. This is an important
element to take into the equation during the shared decision process. Patients may however
value quality of life as more important than quantity[38]. It emerged from our interviews that
a good dialysis was considered a dialysis that allowed them as much enjoyable time as possible.
The practical and concrete realization of this construct however differed between patients,
making it the deepest level of meaning also underlying many other themes. All patients under-
stood that dialysis was a necessity to allow them to life longer, and that they had to forfeit some
time for this. This could be either time actually spent on dialysis, or time spent by waiting to be
connected or for transport, but also time lost to do preferred activities because of fatigue. The
circumstances patients spent their time in during the dialysis session also adds to the lived
experience. For some, this is the cozy atmosphere with socializing, laughing and talking with
other patients and staff. Other patients rationalize their time, e.g. by reading the newspaper on
dialysis rather than at home (“to save time”), or do some administrative work during dialysis.
Still others explain they like to take a nap to regain strength for when dialysis is finished. Still
other patients loathed the presence of alarms, as they disturbed their impression of a relaxed,
homely atmosphere. A good dialysis is according to patients present when all these factors are
facilitated by the procedure and staff.
Fatigue often emerged from the interviews as an important symptom associated with ade-
quacy of dialysis. It is often neglected that many patients also loose quality time because of
long time to recover from dialysis. Recovery time after dialysis not only reduces quality of life,
it is also associated with mortality. For patients, a good dialysis is thus the dialysis that results
in as short dialysis recovery time as possible. However, a lower ultrafiltration rate and blood
pump speed are associated with shorter recovery time, but also result in more time spent on
dialysis, which is by many patients in itself associated with non-good dialysis. It is thus of
importance to explain to patients why these interventions are being done. In addition, whereas
for some patients, fatigue was induced by dialysis, and good dialysis was thus a dialysis that did
not induce fatigue, for others, dialysis washed out their fatigue due to accumulation of toxins.
The latter patients saw a positive correlation with the duration or frequency of dialysis and the
degree of fatigue, and assessed the adequacy of dialysis on that.
Strengths and limitation of the study
We restricted our systematic search to the terms adequacy of dialysis and dialysis adequacy, to
enhance consistency. However, this implied we eliminated articles which only used terms such
as ‘dialysis efficacy’ and ‘adequate dialysis dose’. Some might argue that these terms cover the
same definition. The reasons we opted to restrict the terms is that we intended to be as objec-
tive as possible in our review of the scope of the specific term of adequacy of dialysis, limiting
the used search terms. As we started our research from a deduction of the SONG conclusion
with the particular interest to discover the broad meaning of a construct so highly ranked by
patients, using other terms could have provoked other responses in patients. Last, when broad-
ening the scope of used words, we would have created a subjectivity as we would predetermine
which words to be valid synonyms for adequacy of dialysis and which not.
We decided not to include caregivers (both professional as lay persons) in our analysis, as
we judged this to be a very different group of stakeholders, with most likely still a very different
understanding of the concept of dialysis adequacy. For professional caregivers, the biochemical
approach as presented in the literature provides clarity and marking points for assessment,
and as such might be appealing. In the SONG-HD initiative, there was no clear agreement in
the priority of different outcomes between professionals and patients. During the consensus
Dialysis adequacy standardised outcomes
PLOS ONE | https://doi.org/10.1371/journal.pone.0207045 February 5, 2019 13 / 20
conference, health professionals suggested that patients may prioritize outcomes based on the
extent they were educated about the “consequences” of certain outcomes[35]. For lay person
caregivers the picture is probably more confusing, although it is unlikely to co-incide
completely with the biochemical approach of the literature. Anyhow, it would be interesting to
have more in-depth insights in the meaning of the construct adequacy of dialysis for these two
important stakeholder groups, and further research on this is certainly warranted.
Another potential limitation of the qualitative aspect of this study is related to generalizabil-
ity due to health literacy and language barriers. As ‘dialysis adequacy’ is an English term, even
a B2 word in the CEFR classification [39], we needed to translate it to Dutch for patients to
understand it. We did this by applying forward and backward translations using different
translators for both directions. Whereas this translation problem can be seen as a limitation of
our current research, it would be interested to repeat the semi-structured interviews with both
native as non-native speaking patients, to clarify whether the problem is really a language
problem (so meaning is changed during translation) or rather a conceptual problem (patients
do really consider different items under the construct than researchers do). The interviews
strongly suggest that patients intrinsically do attribute different meanings to the construct ade-
quacy of dialysis, and that this difference in interpretation is not, at least not solely, induced by
imperfect translation.
Although not formally measured, we can presume that health literacy plays an important
role in the appreciation of adequacy of dialysis [40]. Knowing the working mechanism of a
dialysis and understanding the long term consequences of high amounts of toxins and fluid
overload may make people focus more on items related with the technical aspects of the dialy-
sis session itself. We could therefore assume the results would be different in for example a
home dialysis population. Also the age of the patient might be of importance. In older or frail
patients, healthcare workers probably focus more on quality of life as there are less QALYs to
gain with stricter regulations of for example phosphate levels [41]. This will make communica-
tion different than in younger patients, being less rigid and less focused on long term
outcomes.
As we were primarily interested in the potential array of themes that emerged when patients
are confronted with the construct adequacy of dialysis we chose for thematic analysis and pur-
posefully interviewed a diversified patient population in terms of age, gender, dialysis vintage
and hemodialysis modality. Within our research setting of a rather small, regional dialysis unit
providing in centre dialysis, several interviews contained repetitive information, although
every individual patient has his/her own way to explain this term. We believe that, although no
new concepts emerged in our research group, different themes might emerge if we would
interview patients in settings of home based therapies. Indeed, these patients most likely are
more into the technical details of the treatment, and amongst them, other understandings of
adequacy of dialysis might exist. As such, we might not truly have reached saturation, and fur-
ther exploration in different settings (eg home dialysis) is certainly warranted. We opted not to
include home dialysis patients in this study however, as they are a separate group, and repre-
sent a small minority of patients in Europe. It has been documented that 12 interviews in most
cases will result in saturation, meaning that additional themes are rarely brought in in follow-
ing interviews[42]. In addition, some authors even consider data saturation not as indispens-
able for thematic analysis[43]. Accordingly, we can at least state that in our setting, the most
prevalent in Belgium and most likely worldwide, there is a discrepancy between patient’s
understanding of the concept of adequacy of dialysis and that found in the literature To further
expand generalizability of our findings, a mixed method approach using questionnaires based
on our themes could be used to quantify their prevalence in a broad dialysis population. In
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order to gain more insights in the deeper meaning patients convey to the construct adequacy
of dialysis, a grounded theory approach will be set up in the future.
Conclusion
The meaning of the construct dialysis adequacy as reported in randomized controlled trials
varies between and within researcher groups and patients. None of the definitions patients
attribute to adequacy of dialysis is purely biochemical as is nearly uniformly the case when the
construct is used in the literature. For patients, the construct rather includes “good enough
dialysis to allow a sufficient time with quality of life”. This is an important notion as most of
the strategies to improve biochemical definitions of adequacy of dialysis are thus in conflict
with what patients appreciate and value. In order to improve shared decision making, evidence
needs to be generated to link both worlds together. A structured approach to produce stan-
dardized outcomes sets, such as the SONG initiative, and a systematic implementation of these
outcomes in randomized controlled trials is necessary to resolve this discrepancy.
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